These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22157924

  • 1. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.
    Valenti L, Motta BM, Alisi A, Sartorelli R, Buonaiuto G, Dongiovanni P, Rametta R, Pelusi S, Fargion S, Nobili V.
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):588-93. PubMed ID: 22157924
    [Abstract] [Full Text] [Related]

  • 2. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [Abstract] [Full Text] [Related]

  • 3. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 4. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 5. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, Miele L, Consonni D, Fatta E, Lombardi R, Marchesini G, Fargion S.
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [Abstract] [Full Text] [Related]

  • 6. A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.
    Nobili V, Donati B, Panera N, Vongsakulyanon A, Alisi A, Dallapiccola B, Valenti L.
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):632-6. PubMed ID: 24345846
    [Abstract] [Full Text] [Related]

  • 7. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q, Li YY, Nie YQ, Zhou YJ, DU YL, Sha WH, Wang H.
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD, Kong LL.
    Gene; 2013 Oct 25; 529(2):340-4. PubMed ID: 23954219
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep 25; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, Omagari K, Kusumoto Y, Yanagi K, Inoue O, Kinoshita N, Ishibashi H, Yano M, Eguchi K.
    Liver Int; 2008 Apr 25; 28(4):519-24. PubMed ID: 17976158
    [Abstract] [Full Text] [Related]

  • 13. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar 25; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.
    Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Fujita K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K, Nakajima A.
    Liver Int; 2009 Aug 25; 29(7):1078-85. PubMed ID: 19302184
    [Abstract] [Full Text] [Related]

  • 17. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M, La Mura V, Bruno S, Gaeta GB, Vecchione R, Carrino F, Moschella F, Torella R, Persico M.
    J Viral Hepat; 2007 Oct 25; 14(10):714-20. PubMed ID: 17875006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
    Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.
    Hepatology; 2006 Oct 25; 44(4):857-64. PubMed ID: 17006922
    [Abstract] [Full Text] [Related]

  • 20. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
    Nobili V, Alkhouri N, Bartuli A, Manco M, Lopez R, Alisi A, Feldstein AE.
    Pediatr Res; 2010 Jun 25; 67(6):665-70. PubMed ID: 20496475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.